Journal News

Lipid profiles reveal sex differences in type 2 diabetes

Jessica Desamero
Oct. 29, 2025

Type 2 diabetes, or T2D, is a metabolic disorder that affects global communities disproportionally. For example, South Asians face a particularly high risk. Changes in lipid species affect T2D, but scientists have not identified any reliable lipid biomarkers. Fatty acids, or FAs, are the major components of many lipids, and they can be potential lipid biomarkers. However, conflicting findings have left unclear how essential FAs relate to T2D development.

In a recent study in the Journal of Lipid Research, Madhusmita Rout and a team of researchers at the University of Oklahoma Health Sciences Center investigated the lipid profiles of individuals from a well-characterized cohort of Asian Indians. They found that in T2D, levels of two key cell membrane components — sphingomyelin and phosphatidylcholines — decreased, while free FAs and lysophosphatidylcholines, or LPCs, increased. After adjusting for age, sex and body mass index, or BMI, they saw significant increases in several essential FAs, such as the omega-6 FA arachidonic acid and the omega-3 FA docosahexaenoic acid. However, in obese individuals, most omega-3 and omega-6 FAs were reduced two- to six-fold. The team also observed sex- and age-related lipid differences. For example, one LPC type was elevated in men of all ages but rose in women only after menopause.

Ultimately, this study identified potentially useful lipid biomarkers that could possibly affect the development of T2D and obesity. Future directions include clarifying the relationship between omega FAs and T2D, as well as the role of essential FAs in human metabolic diseases.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jessica Desamero

Jessica Desamero is a graduate of the biochemistry Ph.D. program at the City University of New York Graduate Center and an ASBMB volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Sizing up cells: How stem cells know when to divide
News

Sizing up cells: How stem cells know when to divide

March 12, 2026

Stanford University researchers find that stem cells control their size early in cell division across living multicellular systems.

When oncogenes collide in brain development
Journal News

When oncogenes collide in brain development

March 10, 2026

Researchers at University Medical Center Hamburg, found that elevated oncoprotein levels within the Wnt pathway can disrupt the brain cell extracellular matrix, suggesting a new role for LIN28A in brain development.

The data that did not fit
Research Spotlight

The data that did not fit

March 5, 2026

Brent Stockwell’s perseverance and work on the small molecule erastin led to the identification of ferroptosis, a regulated form of cell death with implications for cancer, neurodegeneration and infection.

Building a career in nutrition across continents
Profile

Building a career in nutrition across continents

March 3, 2026

Driven by past women in science, Kazi Sarjana Safain left Bangladesh and pursued a scientific career in the U.S.

Avoiding common figure errors in manuscript submissions
How-to

Avoiding common figure errors in manuscript submissions

Feb. 27, 2026

The three figure issues most often flagged during JBC’s data integrity review are background signal errors, image reuse and undeclared splicing errors. Learn how to avoid these and prevent mistakes that could impede publication.

Ragweed compound thwarts aggressive bladder and breast cancers
Journal News

Ragweed compound thwarts aggressive bladder and breast cancers

Feb. 26, 2026

Scientists from the University of Michigan reveal the mechanism of action of ambrosin, a compound from ragweed, selectively attacks advanced bladder and breast cancer cells in cell-based models, highlighting its potential to treat advanced tumors.